Company’s 36-month beta value is 0.58.Analysts have differing opinions on the stock, with 5 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for IRON is 15.52M, and currently, short sellers hold a 10.24% ratio of that floaft. The average trading volume of IRON on October 18, 2024 was 211.99K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IRON) stock’s latest price update
Disc Medicine Inc (NASDAQ: IRON)’s stock price has soared by 5.21 in relation to previous closing price of 47.99. Nevertheless, the company has seen a gain of 6.36% in its stock price over the last five trading days. globenewswire.com reported 2024-10-11 that WATERTOWN, Mass., Oct. 11, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced upcoming clinical data to be presented at the 2024 American Society of Nephrology (ASN) Kidney Week, which will be held in San Diego, CA on October 24-27, 2024. The poster will report on additional SAD cohorts from the Phase 1b, randomized, placebo-controlled study of DISC-0974 in patients with non-dialysis dependent chronic kidney disease (NDD CKD) and anemia. This study was designed to assess safety as well as changes to hepcidin, iron, and key hematologic parameters.
IRON’s Market Performance
Disc Medicine Inc (IRON) has experienced a 6.36% rise in stock performance for the past week, with a 5.96% rise in the past month, and a 11.21% rise in the past quarter. The volatility ratio for the week is 4.28%, and the volatility levels for the past 30 days are at 4.41% for IRON. The simple moving average for the past 20 days is 3.81% for IRON’s stock, with a 4.36% simple moving average for the past 200 days.
Analysts’ Opinion of IRON
Wells Fargo, on the other hand, stated in their research note that they expect to see IRON reach a price target of $75. The rating they have provided for IRON stocks is “Overweight” according to the report published on August 22nd, 2024.
Raymond James gave a rating of “Outperform” to IRON, setting the target price at $40 in the report published on April 01st of the current year.
IRON Trading at 4.21% from the 50-Day Moving Average
After a stumble in the market that brought IRON to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.94% of loss for the given period.
Volatility was left at 4.41%, however, over the last 30 days, the volatility rate increased by 4.28%, as shares surge +3.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +22.34% upper at present.
During the last 5 trading sessions, IRON rose by +6.36%, which changed the moving average for the period of 200-days by -15.47% in comparison to the 20-day moving average, which settled at $48.64. In addition, Disc Medicine Inc saw -12.59% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IRON starting from White William Richard, who sale 201 shares at the price of $51.31 back on Oct 01 ’24. After this action, White William Richard now owns 0 shares of Disc Medicine Inc, valued at $10,312 using the latest closing price.
Savage William Jacob, the Chief Medical Officer of Disc Medicine Inc, sale 1,500 shares at $47.41 during a trade that took place back on Sep 16 ’24, which means that Savage William Jacob is holding 40,405 shares at $71,115 based on the most recent closing price.
Stock Fundamentals for IRON
The total capital return value is set at -0.23. Equity return is now at value -21.16, with -20.35 for asset returns.
Based on Disc Medicine Inc (IRON), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -40.43.
Currently, EBITDA for the company is -91.03 million with net debt to EBITDA at 4.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 25.02.
Conclusion
In a nutshell, Disc Medicine Inc (IRON) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
